Shares of Tilray Inc (NASDAQ:TLRY - Get Free Report) traded up 3.4% on Wednesday . The company traded as high as $0.48 and last traded at $0.47. 7,855,447 shares traded hands during mid-day trading, a decline of 74% from the average session volume of 29,703,459 shares. The stock had previously closed at $0.46.
Wall Street Analyst Weigh In
A number of research firms have issued reports on TLRY. Piper Sandler decreased their target price on Tilray from $2.00 to $1.00 and set a "neutral" rating on the stock in a research report on Wednesday. Canaccord Genuity Group lifted their price target on shares of Tilray from $2.00 to $3.00 and gave the company a "buy" rating in a report on Monday, January 13th.
View Our Latest Stock Analysis on TLRY
Tilray Stock Performance
The company has a market cap of $457.01 million, a price-to-earnings ratio of -1.62 and a beta of 1.88. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.58 and a current ratio of 2.54. The company has a fifty day moving average of $0.73 and a two-hundred day moving average of $1.17.
Tilray (NASDAQ:TLRY - Get Free Report) last announced its quarterly earnings results on Tuesday, April 8th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.06). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The firm had revenue of $185.78 million for the quarter, compared to analyst estimates of $213.38 million. Equities research analysts anticipate that Tilray Inc will post -0.2 EPS for the current year.
Institutional Trading of Tilray
Several institutional investors have recently modified their holdings of the business. Lido Advisors LLC acquired a new position in Tilray during the 4th quarter worth about $28,000. Verdence Capital Advisors LLC bought a new stake in Tilray in the fourth quarter valued at approximately $29,000. Dudley Capital Management LLC bought a new position in Tilray during the 4th quarter worth approximately $29,000. Ameritas Advisory Services LLC acquired a new position in shares of Tilray in the 4th quarter worth approximately $32,000. Finally, Newman Dignan & Sheerar Inc. boosted its stake in shares of Tilray by 61.9% in the 4th quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock valued at $35,000 after purchasing an additional 10,000 shares during the last quarter. Institutional investors own 9.35% of the company's stock.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
See Also
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
